{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:14:42Z","timestamp":1779923682122,"version":"3.53.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbi.2023.06.016","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:25:57Z","timestamp":1687368357000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy"],"prefix":"10.1016","volume":"113","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2023.06.016_b0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12974-021-02260-6","article-title":"Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology","volume":"18","author":"Afia","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.bbi.2023.06.016_b0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.bbi.2023.06.016_b0015","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1038\/s41380-022-01552-4","article-title":"The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments","volume":"27","author":"Almulla","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0020","doi-asserted-by":"crossref","unstructured":"Balog, E., Jenei, G., Gellert, L., Ono, E., Vecsei, L., Toldi, J., Kis, Z., 2021. Species-specific neuronal localization of kynurenine aminotransferase-2 in the mouse cerebellum. Neurochem. Int. 142, 104920.","DOI":"10.1016\/j.neuint.2020.104920"},{"key":"10.1016\/j.bbi.2023.06.016_b0025","doi-asserted-by":"crossref","unstructured":"Beck, K., Hindley, G., Borgan, F., Ginestet, C., McCutcheon, R., Brugger, S., Driesen, N., Ranganathan, M., D'Souza, D.C., Taylor, M., Krystal, J.H., Howes, O.D., 2020. Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis. JAMA Netw Open 3, e204693.","DOI":"10.1001\/jamanetworkopen.2020.4693"},{"issue":"10","key":"10.1016\/j.bbi.2023.06.016_b0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pcn.12906","article-title":"Effects of electroconvulsive therapy in the systemic inflammatory balance of patients with severe mental disorder","volume":"73","author":"Bioque","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2023.06.016_b0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/HRP.0000000000000321","article-title":"Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies","volume":"30","author":"Bishop","year":"2022","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-017-0962-y","article-title":"Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder","volume":"14","author":"Boerrigter","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"14","key":"10.1016\/j.bbi.2023.06.016_b0045","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1017\/S0033291719001995","article-title":"An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis","volume":"49","author":"\u00c7akici","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2023.06.016_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2021.01.018","article-title":"Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis","volume":"123","author":"Cao","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2023.06.016_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.euroneuro.2023.03.014","article-title":"Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia","volume":"72","author":"Chen","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.06.016_b0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbi.2022.10.022","article-title":"Minocycline, a classic antibiotic, exerts psychotropic effects by normalizing microglial neuroinflammation-evoked tryptophan-kynurenine pathway dysregulation in chronically stressed male mice","volume":"107","author":"Cheng","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.06.016_b0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0070","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3389\/fimmu.2019.02971","article-title":"Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations","volume":"10","author":"De Picker","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2023.06.016_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/08039488.2021.1992647","article-title":"Increased plasma level of kynurenic acid in drug-free patients with first-episode schizophrenia compared to patients with chronic schizophrenia and healthy controls: preliminary data","volume":"76","author":"Ding","year":"2022","journal-title":"Nord. J. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.bbi.2023.06.016_b0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2006.07.011","article-title":"Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia","volume":"149","author":"Fan","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2023.06.016_b0085","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1038\/srep17799","article-title":"Xanthurenic Acid Activates mGlu2\/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia","volume":"5","author":"Fazio","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2023.06.016_b0090","doi-asserted-by":"crossref","unstructured":"Fillman, S.G., Sinclair, D., Fung, S.J., Webster, M.J., Shannon Weickert, C., 2014. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry 4, e365.","DOI":"10.1038\/tp.2014.8"},{"issue":"8","key":"10.1016\/j.bbi.2023.06.016_b0095","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/mp.2015.90","article-title":"Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume","volume":"21","author":"Fillman","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2023.06.016_b0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biopsych.2013.12.002","article-title":"The cytokine model of schizophrenia: emerging therapeutic strategies","volume":"75","author":"Girgis","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0105","article-title":"Electroconvulsive stimulation attenuates chronic neuroinflammation. JCI","volume":"5","author":"Goldfarb","year":"2020","journal-title":"Insight"},{"key":"10.1016\/j.bbi.2023.06.016_b0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2021.05.007","article-title":"Electric neurostimulation regulates microglial activation via retinoic acid receptor alpha signaling","volume":"96","author":"Goldfarb","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.06.016_b0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbi.2021.11.019","article-title":"Inflammatory Subtypes in Antipsychotic-Naive First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization","volume":"100","author":"Hoang","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.06.016_b0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2022.08.001","article-title":"Elevated salivary kynurenic acid levels related to enlarged choroid plexus and severity of clinical phenotypes in treatment-resistant schizophrenia","volume":"106","author":"Huang","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.06.016_b0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jpsychires.2021.11.002","article-title":"Serum kynurenine metabolites might not be associated with risk factors of treatment-resistant schizophrenia","volume":"145","author":"Huang","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2023.06.016_b0130","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3389\/fimmu.2018.02230","article-title":"C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls","volume":"9","author":"Jacomb","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2023.06.016_b0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00702-018-1838-8","article-title":"Kynurenine is correlated with IL-1beta in plasma of schizophrenia patients","volume":"125","author":"Joaquim","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.bbi.2023.06.016_b0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/YCT.0000000000000303","article-title":"Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia","volume":"32","author":"Kartalci","year":"2016","journal-title":"J. ECT"},{"issue":"11","key":"10.1016\/j.bbi.2023.06.016_b0145","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbi.2020.10.026","article-title":"Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment","volume":"91","author":"Krynicki","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.06.016_b0155","doi-asserted-by":"crossref","unstructured":"Labonte, C., Zhand, N., Park, A., Harvey, P.D., 2022. Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation. Psychiatry Res 308, 114382.","DOI":"10.1016\/j.psychres.2021.114382"},{"key":"10.1016\/j.bbi.2023.06.016_b0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12974-016-0688-2","article-title":"Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat","volume":"13","author":"Limoa","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.bbi.2023.06.016_b0165","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.bbi.2023.06.016_b0170","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/s41380-020-00914-0","article-title":"Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis","volume":"26","author":"Lizano","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1819.2012.02354.x","article-title":"Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages","volume":"66","author":"Mansur","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2023.06.016_b0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.016_b0185","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations","volume":"44","author":"Muller","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.016_b0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41398-021-01764-2","article-title":"Peripheral NF-kappaB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-kappaB kinases","volume":"12","author":"Murphy","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2023.06.016_b0195","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","article-title":"Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors","volume":"38","author":"Neale","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2023.06.016_b0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/JCP.0b013e3181f2288e","article-title":"Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF","volume":"30","author":"Nikisch","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2023.06.016_b0205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41398-021-01742-8","article-title":"A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone","volume":"11","author":"North","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2021.01.014","article-title":"Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1beta levels in patients with schizophrenia spectrum disorder and their siblings","volume":"229","author":"Noyan","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.06.016_b0215","article-title":"Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study","volume":"12","author":"Okamoto","year":"2021","journal-title":"Front. Psych."},{"issue":"8","key":"10.1016\/j.bbi.2023.06.016_b0220","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/PSY.0000000000000352","article-title":"Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies","volume":"78","author":"Okusaga","year":"2016","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2023.06.016_b0225","doi-asserted-by":"crossref","first-page":"1005937","DOI":"10.3389\/fimmu.2022.1005937","article-title":"Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy","volume":"13","author":"Pagni","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2023.06.016_b0230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbi.2023.06.016_b0235","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.016_b0240","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/schbul\/sby038","article-title":"The Emerging Immunogenetic Architecture of Schizophrenia","volume":"44","author":"Pouget","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.06.016_b0245","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2174\/092986711795656072","article-title":"Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases","volume":"18","author":"Prendergast","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbi.2023.06.016_b0250","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0255","doi-asserted-by":"crossref","unstructured":"Sathyasaikumar, K.V., Perez de la Cruz, V., Pineda, B., Vazquez Cervantes, G.I., Ramirez Ortega, D., Donley, D.W., Severson, P.L., West, B.L., Giorgini, F., Fox, J.H., Schwarcz, R., 2022. Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma. Antioxidants (Basel) 11.","DOI":"10.3390\/antiox11020315"},{"issue":"7","key":"10.1016\/j.bbi.2023.06.016_b0260","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.06.016_b0265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2023.06.016_b0270","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2013significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2023.06.016_b0275","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/schbul\/sbz037","article-title":"Electroconvulsive Therapy for Treatment-Resistant Schizophrenia","volume":"45","author":"Sinclair","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"13","key":"10.1016\/j.bbi.2023.06.016_b0280","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.3390\/ijms22136974","article-title":"A Role for Xanthurenic Acid in the Control of Brain Dopaminergic Activity","volume":"22","author":"Taleb","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2023.06.016_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070734","article-title":"Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway","volume":"9","author":"Tanaka","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbi.2023.06.016_b0290","doi-asserted-by":"crossref","unstructured":"Thabet, S.G., Moursi, Y.S., Karam, M.A., Borner, A., Alqudah, A.M., 2020. Natural Variation Uncovers Candidate Genes for Barley Spikelet Number and Grain Yield under Drought Stress. Genes (Basel) 11.","DOI":"10.3390\/genes11050533"},{"issue":"11","key":"10.1016\/j.bbi.2023.06.016_b0295","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1111\/ejn.15232","article-title":"Brain stimulation effects on serum BDNF, VEGF, and TNF\u03b1 in treatment-resistant psychiatric disorders","volume":"53","author":"Valiuliene","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2023.06.016_b0300","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","article-title":"Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study","volume":"79","author":"Williams","year":"2022","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2023.06.016_b0305","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical","year":"2013","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.bbi.2023.06.016_b0310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2215-0366(18)30049-X","article-title":"Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study","volume":"5","author":"Yu","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2023.06.016_b0315","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Catts, V.S., Sheedy, D., McCrossin, T., Kril, J.J., Shannon Weickert, C., 2016. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry 6, e982.","DOI":"10.1038\/tp.2016.238"},{"key":"10.1016\/j.bbi.2023.06.016_b0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpsychires.2021.05.004","article-title":"Kynurenine metabolism and metabolic syndrome in patients with schizophrenia","volume":"139","author":"Zhang","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2023.06.016_b0325","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2022.06.012","article-title":"Inflammation-related transcripts define \u201chigh\u201d and \u201clow\u201d subgroups of individuals with schizophrenia and bipolar disorder in the midbrain","volume":"105","author":"Zhu","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.06.016_b0330","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159123001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:19:25Z","timestamp":1760170765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159123001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":66,"alternative-id":["S0889159123001605"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.06.016","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}